Rethinking Clinical Trials Grand Rounds: A Phase 2 Trial of Pridopidine in ALS
Date: Friday, April 11, 2025 1:00 pm - 2:00 pm
Categories:
Other Sponsor
A Phase 2 Trial of Pridopidine in ALS, Studied as a Regimen with the Healey Platform Trial
This NIH Collaboratory Rethinking Clinical Trials Grand Rounds features:
Jeremy M. Shefner, MD, PhD
Professor of Neurology
Barrow Neurological Institute